Effect of ksheerabala taila capsules in knee osteoarthritis

Effect of Ksheerabala taila 101 avartita soft gel capsules in geriatric patients with Sandhigata Vata with special reference to Knee Osteoarthritis - A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063963

Enrollment

Registered

2024-03-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Signs and Symptoms of Sandhigata vata as per ayurvedic classics Patients fulfilling the diagnostic criteria and diagnosed previously as per American College of Rheumatology classification criteria of OA of knee Affected Knee joint is single or both knees Pain in the knee joint greater than or equal to 3 months

Exclusion criteria

Exclusion criteria: Gross disability like bedridden and confined to wheelchair Patients with Rheumatic Arthritis Gout Osteoporosis and other Musculoskeletal system disorders Patients with other major systematic disorders which interfere with treatment will be excluded like Uncontrolled Diabetic Mellitus and Hypertension Patients with ligamental or any other knee joint injury Patients with history of Knee surgery Use of NSAIDS Analgesics Intra articular steroid injections within the past period of 2 weeks

Design outcomes

Primary

Measure	Time frame
Primary Assessment Interleukin 6 Pain Visual Analogue Scale Western Ontario and McMaster University Osteoarthritis Index WHO Quality Of Life BREF Ayurverdic Assessment Parameters Sandhi shoola Sandhi sotha Sandhi stabdatha Sandhi atopaTimepoint: Primary Assessment Interleukin 6 on baseline and 4th week Pain Visual Analogue Scale on baseline 2nd week and 4th week Western Ontario and McMaster University Osteoarthritis Index on baseline and 4th week WHO Quality Of Life BREF on baseline and 4th week Ayurverdic Assessment Parameters Sandhi shoola Sandhi sotha Sandhi stabdatha Sandhi atopa On baseline 2nd week and 4th week	—

Measure

Time frame

Primary Assessment Interleukin 6 Pain Visual Analogue Scale Western Ontario and McMaster University Osteoarthritis Index WHO Quality Of Life BREF Ayurverdic Assessment Parameters Sandhi shoola Sandhi sotha Sandhi stabdatha Sandhi atopaTimepoint: Primary Assessment Interleukin 6 on baseline and 4th week Pain Visual Analogue Scale on baseline 2nd week and 4th week Western Ontario and McMaster University Osteoarthritis Index on baseline and 4th week WHO Quality Of Life BREF on baseline and 4th week Ayurverdic Assessment Parameters Sandhi shoola Sandhi sotha Sandhi stabdatha Sandhi atopa On baseline 2nd week and 4th week

—

Secondary

Measure	Time frame
Goniometry of the Knee joint Walking speedTimepoint: Goniometry on 0th day and 30th day Walking speed on 0th day 15th day and 30th day	—

Countries

India

Contacts

Public ContactDr Kashavva V Hiremath

KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya

kvhiremath.kaher@kleayurworld.edu.in9448945687

Outcome results